Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma

References

• Rizvi S, Khan SA, Hallemeier CL, et al. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15:95–111.
   PubMed Web of Science ®Google Scholar
• Krasinskas AM. Cholangiocarcinoma. Surg Pathol Clin. 2018;11:403–429.
   PubMedGoogle Scholar
• Olaizola P, Perugorria MJ, Banales JM. Toward personalized medicine for intrahepatic cholangiocarcinoma: pharmacogenomic stratification of patients. Hepatology. 2018;68:811–814.
   PubMed Web of Science ®Google Scholar
• Sripa B, Pairojkul C. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol. 2008; 24:349–356.
   PubMed Web of Science ®Google Scholar
• Xiao J, Zhu J, Liu Z, et al. Role of surgical treatment for hepatolithiasis-associated intrahepatic cholangiocarcinoma: a retrospective study in a single institution. J Can Res Ther. 2017;13:756–760.
   PubMed Web of Science ®Google Scholar
• Kim BJ, Hyung J, Yoo C, et al. Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients. Cancer Chemother Pharmacol. 2017;80:209–215.
   PubMed Web of Science ®Google Scholar
• Dvorak P, Hoffmann P, Brodak M, et al. Percutaneous radiofrequency and microwave ablation in the treatment of renal tumors-10 years of experience. Wideochir Inne Tech Maloinwazyjne. 2017;12:394–402.
   PubMedGoogle Scholar
• Ferguson CD, Luis CR, Steinke K. Safety and efficacy of microwave ablation for medically inoperable colorectal pulmonary metastases: single-centre experience. J Med Imaging Radiat Oncol. 2017;61:243–249.
   PubMed Web of Science ®Google Scholar
• Mohkam K, Dumont PN, Manichon AF, et al. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm. J Hepatol. 2018;68:1172–1180.
   PubMed Web of Science ®Google Scholar
• Chiou YY, Hwang JI, Chou YH, et al. Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma. Kaohsiung J Med Sci. 2005;21:304–309.
   PubMedGoogle Scholar
• Samimi K, White JK, Brace CL, et al. Monitoring microwave ablation of ex vivo bovine liver using ultrasonic attenuation imaging. Ultrasound Med Biol. 2017;43:1441–1451.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Che Y, Yu S, et al. US-guided percutaneous radiofrequency versus microwave ablation for benign thyroid nodules: a prospective multicenter study. Sci Rep. 2017;7:9554.
   PubMed Web of Science ®Google Scholar
• Wang YM, Qian GJ, Xu Y, et al. Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases. Zhonghua Gan Zang Bing Za Zhi. 2017;25:344–348.
   PubMedGoogle Scholar
• Sohn W, Kang TW, Choi SK, et al. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma. Oncotarget. 2016;7:47794–47807.
   PubMedGoogle Scholar
• Kao WY, Chao Y, Chang CC, et al. Prognosis of early-stage hepatocellular carcinoma: the clinical implications of substages of Barcelona Clinic Liver Cancer system based on a cohort of 1265 patients. Medicine (Baltimore)). 2015;94:e1929.
   PubMed Web of Science ®Google Scholar
• Karaman B, Battal B, Sari S, et al. Hepatocellular carcinoma review: current treatment, and evidence-based medicine. WJG. 2014;20:18059–18060.
   PubMed Web of Science ®Google Scholar
• Su CW, Chau GY, Hung HH, et al. Impact of steatosis on prognosis of patients with early-stage hepatocellular carcinoma after hepatic resection. Ann Surg Oncol. 2015;22:2253–2261.
   PubMed Web of Science ®Google Scholar
• Stasi C, Milani S. Evolving strategies for liver fibrosis staging: non-invasive assessment. WJG. 2017;23:191–196.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Q, Yu G, et al. Correlation between liver stiffness measured by shear wave elastography and Child–Pugh classification. J Ultrasound Med. 2018;37:2191–2199.
   PubMed Web of Science ®Google Scholar
• Suh SW, Choi YS. Predictors of micrometastases in patients with Barcelona Clinic Liver Cancer classification b hepatocellular carcinoma. Yonsei Med J. 2017;58:737–742.
   PubMed Web of Science ®Google Scholar
• Lei Q, Zhang Y, Ke C, et al. Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma. Exp Ther Med. 2018;15:3074–3079.
   PubMed Web of Science ®Google Scholar
• Pinato DJ, Sharma R, Allara E, et al. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. J Hepatol. 2017;66:338–346.
   PubMed Web of Science ®Google Scholar
• Hiraoka A, Michitaka K, Kumada T, et al. ALBI Score as a novel tool in staging and treatment planning for hepatocellular carcinoma: advantage of ALBI grade for universal assessment of hepatic function. Liver Cancer. 2017;6:377–379.
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman O. Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study. J Cancer Res Clin Oncol. 2018;144:901–908.
   PubMed Web of Science ®Google Scholar
• Zou H, Yang X, Li QL, et al. A comparative study of albumin-bilirubin score with Child–Pugh score, model for end-stage liver disease score and indocyanine green R15 in predicting posthepatectomy liver failure for hepatocellular carcinoma patients. Dig Dis. 2018;36:236–243.
   PubMed Web of Science ®Google Scholar
• Pinato DJ, Sharma R, Citti C, et al. The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma. Aliment Pharmacol Ther. 2018;47:95–103.
   PubMed Web of Science ®Google Scholar
• Kao WY, Su CW, Chiou YY, et al. Hepatocellular carcinoma: nomograms based on the albumin-bilirubin grade to assess the outcomes of radiofrequency ablation. Radiology. 2017;285:670–680.
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. JCO. 2015;33:550–558.
   PubMed Web of Science ®Google Scholar
• Filippiadis DK, Binkert C, Pellerin O, et al. CIRSE quality assurance document and standards for classification of complications: the CIRSE classification system. Cardiovasc Intervent Radiol. 2017;40:1141–1146.
   PubMed Web of Science ®Google Scholar
• Lu MD, Chen JW, Xie XY, et al. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy . Radiology. 2001;221:167–172.
   PubMed Web of Science ®Google Scholar
• Zhang K, Yu J, Yu X, et al. Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma. Int J Hyperthermia. 2018;34:292–297.
   PubMed Web of Science ®Google Scholar
• Durand F, Valla D. Assessment of prognosis of cirrhosis. Semin Liver Dis. 2008;28:110–122.
   PubMed Web of Science ®Google Scholar